Sign in

CIK 0001125345

  • Non-accelerated filer
  • Smaller reporting company

MACROGENICS INC

Sign in to watch
Ticker
MGNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-251-5172
Business address
9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market buy 10% owner bought 200,000 shares at $18.50 ($3,700,320)
  10. 4 Exercise or conversion Sr VP, Research & CSO acquired 2,540 shares (option exercise)
  11. 4 Open-market buy 10% owner bought 200,000 shares at an average $20.56 ($4,111,420)
  12. 4 Open-market buy 10% owner bought 600,000 shares at an average $20.61 ($12,363,480)
  13. 4 Open-market sale Sr VP, BPD & Manufacturing sold 5,000 shares at $25.01 ($125,050)
  14. 4 Exercise or conversion Sr VP, Research & CSO acquired 26,076 shares (option exercise)
  15. 4 Open-market buy 10% owner bought 75,000 shares at $21.74 ($1,630,170)
  16. 4 Open-market buy 10% owner bought 175,000 shares at an average $20.82 ($3,644,005)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Shares withheld for taxes Sr VP, Research & CSO gave up 2,416 shares (to pay taxes)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 9 of 25 · 484 filings